|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
8 August 2016 |
|
Main ID: |
NCT02768376 |
|
Date of registration:
|
03/05/2016 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Spinal for Laparoscopic Cholecystectomy
Sp-Lap |
|
Scientific title:
|
|
|
Date of first enrolment:
|
March 2016 |
|
Target sample size:
|
60 |
|
Recruitment status: |
Recruiting |
|
URL:
|
https://clinicaltrials.gov/show/NCT02768376 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Egypt
| | | | | | | |
|
Contacts
|
|
Name:
|
Alreafey Kandeel, MD |
|
Address:
|
|
|
Telephone:
|
00201008158591 |
|
Email:
|
refa3ey2@yahoo.com |
|
Affiliation:
|
|
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- patients scheduled for laparoscopic cholecystectomy
Exclusion Criteria:
- coagulopathy
- Patient refusal
- previous spine surgery
- Obesity BMI more than 30
Age minimum:
18 Years
Age maximum:
45 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Laparoscopic Cholecystectomy
|
|
Intervention(s)
|
|
Drug: General anesthesia
|
|
Drug: Bupivacaine with Fentanyl (Spinal Anesthesia)
|
|
Primary Outcome(s)
|
|
Patient satisfaction (over a scale from 1 to 4)
[Time Frame: 24 hours]
|
|
Postoperative analgesic consumption (mg morphine)
[Time Frame: 24 hours]
|
|
Secondary ID(s)
|
|
Refa32016
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|